Search Results 891-900 of 17023 for hunger suppression
This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...
The goal of the study is to identify immune responses (immune cell activation and suppression) following local ablation of liver tumors. A Study to Evaluate ...
The purpose of this study is to determine the metabolic effects of Colesevelam, particularly for the ability to lower blood sugar after a meal in type 2 ...
The purpose of this study is to assess esophageal mucosal impedance (MI) in post-POEM achalasia patients with gastroesophageal reflux compared to those without.
The purpose of this research study to compare the effects a hormone cholecystokinin (CCK) in the bloodstream in healthy people and in patients with rapid ...
Mehrdad Hefazi Torghabeh, M.D., focuses his research on myeloid malignancies and hematopoietic cell therapies, with particular emphasis on allogeneic stem cell ...
LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of ...
The purpose of this study is to understanding the mechanisms of weight gain in patients following liver transplantation, action, and indicate approaches to ...
Giving the drugs in different combinations may kill more breast cancer cells. Giving combination chemotherapy after surgery may kill any tumor cells that remain ...
There is evidence that colonic inflammation plays a major role in colon polyp and colorectal cancer development. For example, inflammatory bowel disease is a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!